The Utility of Circulating Tumor DNA (ctDNA) Monitoring in Cancer Patients Who Are Pregnant or Planning to Become Pregnant
The number of pregnant women with cancer is on the rise. These patients and their providers encounter complex medical management decisions. Standard-of-care systemic therapy and radiological imaging can impair fetal development and affect viability. Conversely, insufficient monitoring and treatment...
Saved in:
Main Authors: | Stacey A. Cohen, Anup Kasi, Nicole Hook, Michael Krainock, Griffin Budde, Allyson Koyen Malashevich, Jeffrey Meltzer, Russ Jelsema, Perry Olshan, Paul R. Billings, Alexey Aleshin, Andrew S. Poklepovic |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Case Reports in Obstetrics and Gynecology |
Online Access: | http://dx.doi.org/10.1155/2022/9412201 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Next-generation ctDNA-driven clinical trials in precision immuno-oncology
by: Charu Aggarwal, et al.
Published: (2023-01-01) -
Clinical characteristics of EGFR-ctDNA shedders in EGFR-mutant NSCLC patients
by: Martina Ruglioni, et al.
Published: (2025-02-01) -
The hype around ctDNA guiding an informed perioperative therapeutic strategy in early-stage non-small cell lung cancer
by: Gaia Passarella, et al.
Published: (2025-01-01) -
Pregnant
by: Mary Elizabeth Leighton, et al.
Published: (2024-11-01) -
Percentage of primiparous water buffalo cows becoming pregnant in the first 90 days postpartum
by: Héctor Nava-Trujillo, et al.
Published: (2023-11-01)